WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO1998050049) PREPARATION OF FAGOPYRITOLS AND USES THEREFOR
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/1998/050049    International Application No.:    PCT/US1998/009255
Publication Date: 12.11.1998 International Filing Date: 06.05.1998
Chapter 2 Demand Filed:    04.12.1998    
IPC:
C07H 15/207 (2006.01)
Applicants: CORNELL RESEARCH FOUNDATION, INC. [US/US]; Suite 105, 20 Thornwood Drive, Ithaca, NY 14850 (US)
Inventors: OBENDORF, Ralph, L.; (US).
HORBOWICZ, Marcin; (PL)
Agent: ROGALSKYJ, Peter; Nixon, Hargrave, Devans & Doyle LLP, Clinton Square, P.O. Box 1051, Rochester, NY 14603 (US)
Priority Data:
60/045,927 07.05.1997 US
Title (EN) PREPARATION OF FAGOPYRITOLS AND USES THEREFOR
(FR) PREPARATION DE FAGOPYRITOLS ET LEURS UTILISATIONS
Abstract: front page image
(EN)The present invention describes isolated Fagopyritol A1, isolated Fagopyritol A2, and isolated Fagopyritol B3. Compositions which include two or more of Fagopyritol A1, Fagopyritol A2, Fagopyritol B1, Fagopyritol B2, Fagopyritol B3, and D-$i(chiro)-inositol, at least one of which is an isolated Fagopyritol A1, isolated Fagopyritol A2, or isolated Fagopyritol B3, are also disclosed. Methods for preparing substantially pure Fagopyritol A1, Fagopyritol A2, Fagopyritol B1, Fagopyritol B2, Fagopyritol B3, or mixtures thereof from buckwheat are also described. The fagopyritols can be used to prepare pharmaceutical compositions, the administration of which can be used to treat diabetes.
(FR)La présente invention concerne un fagopyritol A1 isolé, un fagopyritol A2 isolé et un fagopyritol B3 isolé. Des compositions qui comportent deux ou plusieurs fagopyritols parmi des fagopyritols A1, A2, B1, B2, B3 et D-chiro-isonitol, dont au moins un est un fagopyritol A1 isolé, un fagopyritol A2 isolé ou un fagopyritol B3 isolé sont également décrites. La présente invention concerne en outre des procédés de préparation de fagopyritol A1, de fagopyritol A2, de fagopyritol B1, de fagopyritol B2, de fagopyritol B3 sensiblement purs ou de mélanges desdites substances à partir du sarrasin. Lesdits fagopyritols peuvent être utilisés pour préparer des compositions pharmaceutiques destinées au traitement du diabète.
Designated States: AL, AM, AT, AU, AZ, BA, BB, BG, BR, BY, CA, CH, CN, CU, CZ, DE, DK, EE, ES, FI, GB, GE, GH, GM, GW, HU, ID, IL, IS, JP, KE, KG, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, MD, MG, MK, MN, MW, MX, NO, NZ, PL, PT, RO, RU, SD, SE, SG, SI, SK, SL, TJ, TM, TR, TT, UA, UG, UZ, VN, YU, ZW.
African Regional Intellectual Property Organization (GH, GM, KE, LS, MW, SD, SZ, UG, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LU, MC, NL, PT, SE)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)